doi:10.1172/JCI88871 Weinheimer EM, Sands LP, Campbell WW
In Phase 2 trials, the 8mg dose produced 22.8% average weight loss while 12mg produced 24.2%, a difference of about 1.4%
Patients with pre-existing diagnoses of the respective outcome prior to the BTX-A/GLP-1 receptor agonist index date were excluded from each time-to-event analysis
Starting in 2023, Brown said there were 115 people using prescriptions for about $625,000 a year
Abstract Centrifugal microfluidic platforms are highly regarded for their potential in multiplexing and automation, as well as their wide range of applications, especially in separating blood plasma and manipulating two-phase flows
The total peptide weight listed on the vial is the combined weight of both compounds